MedPath

Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning

Not Applicable
Completed
Conditions
Speech
Motor Activity
Interventions
Behavioral: Speech adaptation
Behavioral: Vibrotactile Discrimination
Other: fMRI
Behavioral: Speech production
Registration Number
NCT04547569
Lead Sponsor
University Hospital, Grenoble
Brief Summary

These studies test the hypothesis that frontal areas of the brain participate in the cortical networks involved in the somotosensory processing that happens during speech motor learning.

Detailed Description

This work aims to study the role of sensory systems in human motor learning and specifically addresses the involvement of somatosensory cortical networks in motor learning of speech. Previous studies in the literature have highlighted the plasticity of cortical sensory networks, notably the primary and secondary somatosensory cortex and the ventral premotor cortex, during motor learning tasks. The present project focuses on the somatosensory region with connections to the sensorimotor regions of the frontal and parietal cortex. We propose to use neuroimaging (fMRI), in order to verify which areas in the prefrontal cortex are part of the sensorimotor network used in the learning of speech motor tasks in humans. Subjects will be tested in the fMRI scanner while performing either a behavioral task in which the auditory feedback of their own speech is altered or while performing a vibrotactile discrimination task.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Right-handed subjects
  • Subjects fluent in French
  • Signed informed consent
  • Affiliation to or beneficiary of a Social Security scheme
Exclusion Criteria
  • Left-handed subjects

  • Criteria for contraindications to protocol fMRI scans

  • Existence of a severe general condition: cardiac, respiratory, hematological, renal, hepatic, cancerous.

  • Hearing, language (including dyslexia), neurological or psychiatric disorders.

  • Participation in other ongoing intervention research protocols with exclusionary period or within the previous week

  • Drug treatment likely to modulate brain activity: benzodiazepines, antidepressants, neuroleptics, lithium, etc.

  • Protected persons referred to in articles L1121 5 to L1121 8 of the French CSP:

    • Pregnant women, parturients, nursing mothers,
    • Persons deprived of liberty by a judicial or administrative decision,
    • Persons under psychiatric care,
    • Individuals admitted to a health or social institution for purposes other than research,
    • Minors,
    • Persons over the age of majority who are subject to a legal protection measure or who are unable to express their consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vibrotactile discriminationfMRIfMRI measurement of brain activity during a vibrotactile discrimination task
Speech productionSpeech productionfMRI measurement of brain activity during normal speech production
Adaptation to altered auditory feedbackfMRIfMRI measurement of brain activity during speech production under altered auditory feedback
Adaptation to altered auditory feedbackSpeech adaptationfMRI measurement of brain activity during speech production under altered auditory feedback
Speech productionfMRIfMRI measurement of brain activity during normal speech production
Vibrotactile discriminationVibrotactile DiscriminationfMRI measurement of brain activity during a vibrotactile discrimination task
Primary Outcome Measures
NameTimeMethod
Brain activity1h30 scanner session

Brain activity are measure by the BOLD signal during both task-based and resting-state blocks

Motor LearningPerformance as measured at the end of learning (during the 1h30 scanner session)

Learning is assessed as percentage change in speech sounds (speech formant frequencies) relative to baseline.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Grenoble-Alpes

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath